HEIDI DIECK: Open Payments
NPI 1376066670 · MONTROSE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,288 in 70 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $191 · 2025 $1,288
Food & beverage: $1,273Education: $15
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $353 |
| Novo Nordisk Inc | 11 | $230 |
| Exact Sciences Corporation | 6 | $116 |
| GlaxoSmithKline, LLC. | 5 | $88 |
| Verona Pharma, Inc. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Lilly USA, LLC | 3 | $56 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Abbott Laboratories | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
Products named: VRAYLAR, Ozempic, The Cologuard Plus Collection Kit, Wegovy, Ohtuvayre, QULIPTA, BREZTRI, TRELEGY ELLIPTA.
Industry payments across PA — which companies pay providers there.
